These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA, Gaudino G, Mutti L, Moro L. Cancer Res; 2009 Jun 01; 69(11):4598-604. PubMed ID: 19487281 [Abstract] [Full Text] [Related]
55. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ, Robinson BW. Thorax; 2007 Jul 01; 62(7):569-76. PubMed ID: 17356060 [Abstract] [Full Text] [Related]
56. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW. Chest; 2007 Oct 01; 132(4):1239-46. PubMed ID: 17646232 [Abstract] [Full Text] [Related]
57. Sensitivity of urinary mesothelin in patients with malignant mesothelioma. Creaney J, Musk AW, Robinson BW. J Thorac Oncol; 2010 Sep 01; 5(9):1461-6. PubMed ID: 20815094 [Abstract] [Full Text] [Related]